| Heart Rate Variability and Anxiety During Urinary Bladder Catheterization (NCT05380661) | University of British Columbia | 2022-07-15 |
| Cystometry Using a Novel Microsensor System in Patients With Neurogenic Bladder Dysfunction (NCT06445426) | Sunnaas Rehabilitation Hospital | 2022-06-01 |
| Multicenter Observational Study for the Evaluation in Clinical Practice of Urinary Disorders in Multiple Sclerosis (NCT05075642) | ASP 7 Ragusa | 2021-11-01 |
| Botulinum Toxin A vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients With Multiple Sclerosis (NCT04819360) | Brigitte Schürch | 2021-06-01 |
| Ambulatory Closed-loop Stimulation for Bladder Control (NCT05740527) | MetroHealth Medical Center | 2021-03-01 |
| Cystoealstometer (Bladder Monitor Device)-Home Use (NCT05232253) | University of Iowa | 2021-01-18 |
| Recovery of Bladder and Sexual Function After Human Spinal Cord Injury (NCT04193709) | University of Louisville | 2021-01-04 |
| Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis (NCT04528784) | University of Limerick | 2020-10-14 |
| Measurement of Bladder Pressure With a Novel External Device (Cystomanometer) - Home Use (NCT04128709) | Christopher Cooper | 2019-11-19 |
| Mirabegron and Oxybutynin Safety and Efficacy Trial in Spinal Cord Injury (NCT03187795) | Kessler Foundation | 2019-04-03 |
| Measurement of Bladder Pressure With a Novel External Device, Comparison to Urodynamics Testing (NCT03456089) | Christopher Cooper | 2018-04-15 |
| Connected Catheter Clinical Feasibility Study( CFS) (NCT03405285) | Spinal Singularity | 2018-02-28 |
| Urinary Disorders in Patients With Multiple Sclerosis: Invasive Vs Non-invasive Investigations. (NCT03336424) | Saint-Joseph University | 2017-10-01 |
| A Prospective Evaluation of the Catheter Science C3 "Umbrella Catheter." (NCT03353571) | Dr. Gaines W. Hammond Jr. MD FACS | 2017-08-31 |
| Pediatric Urology Recovery After Surgery Endeavor (PURSUE) (NCT03245242) | Washington University School of Medicine | 2017-04-01 |
| Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder (NCT02673047) | Allergan | 2016-02-01 |
| Transcutaneous Peripheral Neuromodulation for Neurogenic Bladder (NCT02582151) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2016-01-01 |
| Reduction of Bladder Injection Pain With Belladonna Opiate Suppository (NCT02600715) | Edgar LeClaire, MD | 2015-11-01 |
| Urodynamic and Clinical Efficacy of Mirabegron for Neurogenic Bladder Patients (NCT02044510) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2014-07-01 |
| Evaluation of a Bowel and Bladder Health Management Program for Individuals With Spinal Cord Injury (SCI) (NCT01920243) | University of Michigan | 2013-10-28 |
| Detrusor Contraction During the Ice-water-test (NCT01773213) | Balgrist University Hospital | 2012-12-01 |
| Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology (NCT00629720) | Sanofi | 2006-07-01 |
| Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity (NCT01530620) | APOGEPHA Arzneimittel GmbH | 2004-12-01 |